Lankacidin C 8-acetate | CAS#23812-97-7 | antibiotic

MedKoo Cat#: 598297 | Name: Lankacidin C 8-acetate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lankacidin C 8-acetate is a lankacidin-group (T-2636) antibiotic.

Chemical Structure

Lankacidin C 8-acetate

CAS#23812-97-7

Theoretical Analysis

MedKoo Cat#: 598297

Name: Lankacidin C 8-acetate

CAS#: 23812-97-7

Chemical Formula: C27H35NO8

Exact Mass: 501.2363

Molecular Weight: 501.57

Elemental Analysis: C, 64.66; H, 7.03; N, 2.79; O, 25.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Lankacidin C 8-acetate; 5-18-12-00134 (Beilstein Handbook Reference);

IUPAC/Chemical Name

(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanamido)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-7-yl acetate

InChi Key

SXLMQJVXWZFRNQ-LDACTNBVSA-N

InChi Code

InChI=1S/C27H35NO8/c1-15-7-10-20(31)14-22-17(3)24(32)27(6,26(34)36-22)23(28-25(33)18(4)29)13-16(2)9-12-21(11-8-15)35-19(5)30/h7-10,12-13,17,20-23,31H,11,14H2,1-6H3,(H,28,33)/b10-7+,12-9+,15-8+,16-13+/t17-,20-,21+,22-,23-,27+/m1/s1

SMILES Code

CC(C(N[C@H](/C=C(C)/C=C/[C@@H](OC(C)=O)C/C=C(C)/C=C/[C@@H](O)C[C@@]1([H])O2)[C@](C([C@@H]1C)=O)(C)C2=O)=O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 501.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Nakahama K, Harada S, Igarasi S. Studies on lankacidin-group (T-2636) antibiotics. X. Microbial conversion of lankacidin-group antibiotics. J Antibiot (Tokyo). 1975 May;28(5):390-4. PubMed PMID: 240790. 2: Arakawa K. Genetic and biochemical analysis of the antibiotic biosynthetic gene clusters on the Streptomyces linear plasmid. Biosci Biotechnol Biochem. 2014;78(2):183-9. doi: 10.1080/09168451.2014.882761. Epub 2014 Apr 16. Review. PubMed PMID: 25036669. 3: Hatano K, Harada S, Kishi T. Studies on lankacidin-group (T-2636) ANTIBIOTICS. IX Preparation of C-labeled lankacidin C 14-propionate. J Antibiot (Tokyo). 1975 Jan;28(1):15-20. PubMed PMID: 1126865. 4: Oostu K, Matsumoto T, Harada S, Kishi T. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships. Cancer Chemother Rep. 1975 Sep-Oct;59(5):919-28. PubMed PMID: 1148. 5: Harada S, Tanayama S, Kishi T. Studies on lankacidin-group (T-2636) antibiotics. 8. Metabolism of lankacidin C 14-propionate in rats and mice. J Antibiot (Tokyo). 1973 Nov;26(11):658-68. PubMed PMID: 4792113. 6: Arakawa K, Tsuda N, Taniguchi A, Kinashi H. The butenolide signaling molecules SRB1 and SRB2 induce lankacidin and lankamycin production in Streptomyces rochei. Chembiochem. 2012 Jul 9;13(10):1447-57. doi: 10.1002/cbic.201200149. Epub 2012 Jun 14. PubMed PMID: 22761035. 7: Belousoff MJ, Shapira T, Bashan A, Zimmerman E, Rozenberg H, Arakawa K, Kinashi H, Yonath A. Crystal structure of the synergistic antibiotic pair, lankamycin and lankacidin, in complex with the large ribosomal subunit. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2717-22. doi: 10.1073/pnas.1019406108. Epub 2011 Jan 31. PubMed PMID: 21282615; PubMed Central PMCID: PMC3041097. 8: Kunitake H, Hiramatsu T, Kinashi H, Arakawa K. Isolation and Biosynthesis of an Azoxyalkene Compound Produced by a Multiple Gene Disruptant of Streptomyces rochei. Chembiochem. 2015 Oct 12;16(15):2237-43. doi: 10.1002/cbic.201500393. Epub 2015 Sep 2. PubMed PMID: 26300120. 9: Sawada H, Suzuki T, Akiyama S, Nakao Y. Mechanism of the stimulatory effect of cyclodextrins on lankacidin-producing Streptomyces. Appl Microbiol Biotechnol. 1990 Feb;32(5):556-9. PubMed PMID: 1366439. 10: Williams DR, Rojas CM, Bogen SL. Studies of Acyl Nitrene Insertions. A Stereocontrolled Route toward Lankacidin Antibiotics. J Org Chem. 1999 Feb 5;64(3):736-746. PubMed PMID: 11674141. 11: Tatsuno S, Arakawa K, Kinashi H. Extensive mutational analysis of modular-iterative mixed polyketide biosynthesis of lankacidin in Streptomyces rochei. Biosci Biotechnol Biochem. 2009 Dec;73(12):2712-9. Epub 2009 Dec 7. PubMed PMID: 19966473. 12: Cao Z, Yoshida R, Kinashi H, Arakawa K. Blockage of the early step of lankacidin biosynthesis caused a large production of pentamycin, citreodiol and epi-citreodiol in Streptomyces rochei. J Antibiot (Tokyo). 2015 May;68(5):328-33. doi: 10.1038/ja.2014.160. Epub 2014 Dec 3. PubMed PMID: 25464973. 13: Omura S, Nakagawa A, Fujimoto T, Saito K, Otoguro K, Walsh JC. Hygromycin A, an antitreponemal substance. I. Screening method and therapeutic effect for Treponema hyodysenteriae-caused infection in CF-1 mice. J Antibiot (Tokyo). 1987 Nov;40(11):1619-26. PubMed PMID: 3693130. 14: Kikuchi M, Nakao Y. Mode of action of the protein, SP127, which enhances the activity of macrolide antibiotics against Pseudomonas aeruginosa. J Antibiot (Tokyo). 1977 Mar;30(3):215-20. PubMed PMID: 405356. 15: Okada J, Kondo S. Liquid chromatographic method for determining the macrolide antibiotic sedecamycin and its major metabolites in swine plasma and tissues. J Assoc Off Anal Chem. 1987 Sep-Oct;70(5):818-24. PubMed PMID: 3680117. 16: Yamauchi Y, Nindita Y, Hara K, Umeshiro A, Yabuuchi Y, Suzuki T, Kinashi H, Arakawa K. Quinoprotein dehydrogenase functions at the final oxidation step of lankacidin biosynthesis in Streptomyces rochei 7434AN4. J Biosci Bioeng. 2018 Jun 2. pii: S1389-1723(18)30057-4. doi: 10.1016/j.jbiosc.2018.03.006. [Epub ahead of print] PubMed PMID: 29871824.